Ononin Mitigates Estrogen Deficiency‐Induced Osteoporosis Through Activation of ALDH2 in Mice
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Mingchuan Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Isoflavones, Osteoporosis, Postmenopausal, Estrogens. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Second Affiliated Hospital of Nanchang University-funded Projects.
Abstract (Originalsprache)
Postmenopausal osteoporosis (PMOP) results from estrogen deficiency, oxidative stress, and impaired bone formation, yet effective treatments remain limited. In this study, we identify the natural isoflavone ononin as a potent antiosteoporotic compound and uncover its mechanism through activation of aldehyde dehydrogenase 2 (ALDH2). Using an ovariectomized (OVX) mouse model and bone marrow‐derived mesenchymal stem cells (BMSCs), we evaluated the in vivo and in vitro effects of ononin. An integrated approach combining network pharmacology, molecular docking, enzymatic assays, and ALDH2 knockout ( Aldh2 −/− ) models was employed to verify its molecular target. Ononin significantly alleviated OVX‐induced trabecular bone loss and promoted osteogenic differentiation of BMSCs in a dose‐dependent manner. Mechanistically, network pharmacology and docking analyses identified ALDH2 as the primary target. Enzymatic assays confirmed that ononin robustly enhances ALDH2 activity, reduces reactive oxygen species, lowers 4‐hydroxynonenal and malondialdehyde levels, and maintains mitochondrial integrity. These beneficial effects were largely abolished in Aldh2 −/− mice, confirming the dependence on ALDH2 activation. Collectively, these findings demonstrate that ononin protects against PMOP by promoting ALDH2‐mediated osteogenesis and restoring redox balance, highlighting its potential as a natural therapeutic agent for postmenopausal osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Trauma Emergency Center, Ganzhou People's Hospital, Ganzhou, China.
- Ganzhou City Key Laboratory of Bone Metabolism, Ganzhou, China.
- The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Second Affiliated Hospital of Nanchang University-funded Projects
Zitieren
APA
Yu, M., Ruan, D., Rao, W., Zeng, H., & Chen, X. (2026). Ononin Mitigates Estrogen Deficiency‐Induced Osteoporosis Through Activation of ALDH2 in Mice. Phytotherapy Research. https://doi.org/10.1002/ptr.70258
Vancouver
Yu M, Ruan D, Rao W, Zeng H, Chen X. Ononin Mitigates Estrogen Deficiency‐Induced Osteoporosis Through Activation of ALDH2 in Mice. Phytotherapy Research. 2026. doi:10.1002/ptr.70258
BibTeX
@article{Yu2026,
author = {Yu, Mingchuan and Ruan, Dong and Rao, Wentao and Zeng, Haimin and Chen, Xiang},
title = {Ononin Mitigates Estrogen Deficiency‐Induced Osteoporosis Through Activation of ALDH2 in Mice},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70258}
}
EUVIMED